Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2026-04-16 Audit Report / Informat…
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Audit Report / Information Classification · 91% confidence The document is the full audited consolidated financial statements of Decibel Cannabis Company Inc. for the years ended December 31, 2025 and 2024, including an Independent Auditor’s Report by MNP LLP and detailed notes. It is not a brief announcement or investor presentation; rather, it is a standalone audit report with accompanying statements (excluding the broader management discussion and analysis). Thus, it best fits the Audit Report / Information category. FY 2025
2026-04-16 English
News release - English.pdf
Report Publication Announcement Classification · 85% confidence The document is a press release announcing the timing of Profound Medical Corp.’s first quarter 2026 financial results release and its accompanying conference call. It does not contain any actual financial results or detailed data, but rather informs investors of when the earnings report will be published. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2026-04-16 English
News release - English.pdf
Report Publication Announcement Classification · 87% confidence The document is a corporate press release announcing the date and time for the upcoming first quarter 2026 financial results release and accompanying conference call. It contains no financial data or detailed results—only the publication timing and call details. This fits the “Report Publication Announcement (RPA)” category, which covers announcements regarding the timing or release of company reports.
2026-04-16 English
News release - English.pdf
Regulatory Filings Classification · 45% confidence The document is a press release announcing that management will present at an upcoming investor conference. It does not include financial results, detailed presentation materials, or an attached investor deck—the actual presentation is not embedded. It is not announcing a report publication, nor is it a specific regulatory or financial statement. Therefore, it falls under the general regulatory announcements fallback category.
2026-04-14 English
News release - English.pdf
Investor Presentation Classification · 75% confidence The document is a press release announcing that Profound Medical will present an update on its business at the 2026 Bloom Burton & Co. Healthcare Investor Conference. It is not reporting quarterly results (ER), nor is it a regulatory filing, management change, or financial report. It relates to an upcoming presentation aimed at investors, matching the Investor Presentation (IP) category.
2026-04-14 English
News release - English.pdf
Regulatory Filings Classification · 25% confidence The document is a corporate press release announcing Profound Medical’s participation in presentations at a scientific meeting, with no financial results, regulatory vote details, share transactions, or other specific filing content. It does not contain an actual report, earnings data, management change, or scope matching any specialized category, so it falls into the general regulatory announcements/fallback category.
2026-04-01 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.